Nanoparticles squeezing across the blood–endothelial barrier via caveolae
2013; Future Science Ltd; Volume: 4; Issue: 2 Linguagem: Inglês
10.4155/tde.12.140
ISSN2041-6008
Autores Tópico(s)Erythrocyte Function and Pathophysiology
ResumoTherapeutic DeliveryVol. 4, No. 2 EditorialNanoparticles squeezing across the blood–endothelial barrier via caveolaeZhenjia Wang & Asrar B MalikZhenjia Wang* Author for correspondenceDepartment of Pharmacology & Center for Lung & Vascular Biology, College of Medicine , University of Illinois, Chicago, IL, USA. & Asrar B MalikDepartment of Pharmacology & Center for Lung & Vascular Biology, College of Medicine , University of Illinois, Chicago, IL, USAPublished Online:23 Jan 2013https://doi.org/10.4155/tde.12.140AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: caveolaecaveolae-mediated transportendothelial barriernanotherapeuticsReferences1 Faokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano3,16–20 (2009).Crossref, Medline, Google Scholar2 Wang X, Yang L, Chen Z, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin.58,97–110 (2008).Crossref, Medline, Google Scholar3 Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol. Rev.86,279–367, 2006 (2006).Crossref, Medline, CAS, Google Scholar4 Giordano RJ, Edwards JK, Tuder RM, Arap W, Renata Pasqualini R. Combinatorial ligand-directed lung targeting. Proc. Am. Thorac. Soc.6(5),411–415 (2009).Crossref, Medline, CAS, Google Scholar5 Hashizume H, Baluk P, Morikawa S et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol.156,1363–1380 (2000).Crossref, Medline, CAS, Google Scholar6 Sarin H, Kanevsky AS, Wu H et al. Physiologic upper limit of pore size in the blood–tumor barrier of malignant solid tumors. J. Trans. Med.7,51–63 (2009).Crossref, Medline, Google Scholar7 Zetter BR. Endothelial heterogeneity: influence of vessel size, organ localization and species specificity on the properties of cultured endothelial cells. In: Endothelial Cells Volume 2. Ryan US (Ed.). CRC Press, Boca Raton, FL, USA, 63–79 (1989).Google Scholar8 Sandoval KE, Witt KA. Blood–brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis.32,200–219 (2008).Crossref, Medline, CAS, Google Scholar9 Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu. Rev. Physiol.72,463–493 (2010).Crossref, Medline, CAS, Google Scholar10 Johansson BR. Size and distribution of endothelial plasmalemmal vesicles in consecutive segments of the microvasculature in cat skeletal muscle. Microvasc. Res.17,107–117 (1979).Crossref, Medline, CAS, Google Scholar11 Parton RG, Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell. Biol.8,185–194 (2007).Crossref, Medline, CAS, Google Scholar12 Pelkmans L, Zerial M. Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature436,128–133 (2005).Crossref, Medline, CAS, Google Scholar13 Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vescular-transport pathway to the ER. Nat. Cell Biol.3,573–483 (2001).Crossref, Medline, Google Scholar14 Hill MM, Bastiani M, Luetterforst R et al. PTRF-cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell132,113–124 (2008).Crossref, Medline, CAS, Google Scholar15 Wang Z, Tiruppathi T, Minshall R, Malik AB. Size and dynamics of caveolae using nanoparticles in living endothelial cells. ACS Nano3,4110–4116 (2009).Crossref, Medline, CAS, Google Scholar16 Wang Z, Tiruppathi C, Cho J, Minshall RD, Malik AB. Delivery of nanoparticle-complexed drugs across vascular endothelial barrier via caveolae. IUBMB Life63,659–667 (2011).Crossref, Medline, CAS, Google Scholar17 Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J. Biol. Chem.272,25968–25975 (1997).Crossref, Medline, CAS, Google Scholar18 Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB. Caveolin regulation of endothelial function. Am. J. Physiol. Lung Cell Mol. Physiol.285,L1179–L1183 (2003).Crossref, Medline, CAS, Google Scholar19 Predescu SA, Predescu DN, Malik AB. Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am. J Physiol. Lung. Cell. Mol. Physiol.293,L823–L842 (2007).Crossref, Medline, CAS, Google Scholar20 Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenett PS. Heterotypic interactions enabled by polarized neutrophils microdomains mediate thromboinflammatory injury. Nat. Med.15,384–391 (2009).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByPharmacokinetics of Long Circulating Inorganic Nanoparticulate Drug Delivery Systems8 March 2022Investigation of indoor aerosols emitted from electrical appliancesJournal of Physics: Conference Series, Vol. 1953, No. 1Challenges and barriersCross-linker-Modulated Nanogel Flexibility Correlates with Tunable Targeting to a Sterically Impeded Endothelial Marker10 October 2019 | ACS Nano, Vol. 13, No. 10Recent advances in photodynamic therapy for cancer and infectious diseases6 May 2019 | WIREs Nanomedicine and Nanobiotechnology, Vol. 11, No. 5Influence of PDLA nanoparticles size on drug release and interaction with cells28 November 2018 | Journal of Biomedical Materials Research Part A, Vol. 107, No. 3Outer membrane vesicles for vaccination and targeted drug delivery26 April 2018 | WIREs Nanomedicine and Nanobiotechnology, Vol. 11, No. 2A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs)Biomaterials, Vol. 187Flexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid Nanoparticles28 June 2018 | Advanced Materials, Vol. 30, No. 32Targeting Inflammatory Vasculature by Extracellular Vesicles26 February 2018 | The AAPS Journal, Vol. 20, No. 2Active targeted delivery of immune therapeutics to lymph nodesCurrent Opinion in Organ Transplantation, Vol. 23, No. 1Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug deliveryNanomedicine, Vol. 12, No. 16Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concernNanomedicine, Vol. 12, No. 4Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection5 November 2015 | ACS Nano, Vol. 9, No. 12Effects of nitric oxide on stem cell therapyBiotechnology Advances, Vol. 33, No. 8Nano-Mg(OH)2-induced proliferation inhibition and dysfunction of human umbilical vein vascular endothelial cells through caveolin-1-mediated endocytosis10 January 2015 | Cell Biology and Toxicology, Vol. 31, No. 1Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles1 January 2015 | Nanoscale, Vol. 7, No. 45Mechanisms Regulating Endothelial Permeability1 December 2014 | Pulmonary Circulation, Vol. 4, No. 4 Vol. 4, No. 2 Follow us on social media for the latest updates Metrics Downloaded 201 times History Published online 23 January 2013 Published in print February 2013 Information© Future Science LtdKeywordscaveolaecaveolae-mediated transportendothelial barriernanotherapeuticsFinancial & competing interests disclosureZ Wang acknowledges support from 11SDG7490013 (American Heart Association) and K25HL111157 (NIH) and AB Malik acknowledges support from NIH grants P01HL060678, P01HL077806, and R01HL045638. AB Malik is also the president of the company Cell Biologics with interest in drug delivery via caveolae. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download
Referência(s)